A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61K 38/17 (2006.01) A61K 39/00 (2006.01) A61K 39/39 (2006.01) A61K 48/00 (2006.01) A61P 25/28 (2006.01) C07K 14/47 (2006.01) C07K 16/18 (2006.01) G01N 33/68 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2370311
The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A.beta. in the brain of a patient. Such methods entail administering agents that induce a beneficial immunogenic response against the amyloid deposit. The methods are useful for prophylactic and therapeutic treatment of Alzheimer's disease. Preferred agents including N- terminal fragments of A.beta. and antibodies binding to the same.
L'invention concerne des compositions et des procédés utiles pour le traitement de maladies amyloïdogènes liées au dépôt amyloïde de A.beta. sur l'encéphale d'un patient. De tels procédés consistent à administrer des agents induisant une réponse immunogène utile contre le dépôt amyloïde. Ces procédés sont utiles à des fins de traitements prophylactiques et thérapeutiques de la maladie d'Alzheimer. L'invention concerne également des agents contenant des fragments de N-terminal de A.beta. et des anticorps se fixant à eux.
Bard Frederique
Schenk Dale B.
Vasquez Nicki J.
Yednock Theodore
Gowling Lafleur Henderson Llp
Janssen Alzheimer Immunotherapy
Neuralab Limited
LandOfFree
Prevention and treatment of amyloidogenic disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prevention and treatment of amyloidogenic disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention and treatment of amyloidogenic disease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1753840